HOME › DRUGS › PIRTOBRUTINIB
ACTIVE SUBSTANCE / INN

PIRTOBRUTINIB

Brand name(s): Jaypirca, JAYPIRCA
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Lymphoma, Mantle-Cell
NDA216059
ACTIVE SUBSTANCE
Pirtobrutinib
REGULATORS
FDA · EMA
SPONSORS / MAH
Eli Lilly Nederland B.V., LOXO ONCOL
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
JAYPIRCANDA216059LOXO ONCOLPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
JaypircaEli Lilly Nederland B.V.Authorised30/10/2023Lymphoma, Mantle-Cell

FULL INTELLIGENCE ON PIRTOBRUTINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →